Serial 90363449
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90363449
- Registration number
- 7680541
- Mark type
- Design / logo
- Filed
- 07 Dec 2020
- Published for opposition
- 06 Jul 2021
- Registered
- 04 Feb 2025
- Attorney of record
- Bobby A. Ghajar
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or regenerative medicine products, particularly medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies; Custom production of biological cells for research and scientific purposes for others; Treatment of materials in the nature of biological cells by means of processing them
Owner
- Cellares Corporation, South San Francisco, CA, US
- Cellares Corporation, South San Francisco, CA, US
- Cellares Corporation, South San Francisco, CA, US
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Jan 2025 — ASSIGNED TO LIE
- 01 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Oct 2024 — NON-FINAL ACTION E-MAILED
- 28 Oct 2024 — SU - NON-FINAL ACTION - WRITTEN
- 08 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Aug 2024 — USE AMENDMENT FILED
- 08 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL